Vascular Surgery OS
Start learning
← All domains
Procedure guide

EVAR

EVAR reduces aneurysm rupture risk by sealing a stent graft between the infrarenal aorta and iliac arteries. Seal excludes the sac; fixation prevents migration. Both are essential. [1,3]

Written August 20, 2026 · Mr Razhan K Ali

1. Purpose & indications

For elective repair, choose standard EVAR when repair is indicated, anatomy meets the device’s instructions for use (IFU), and expected benefit outweighs operative risk and follow-up burden. Frailty, life expectancy and patient preference matter; being unfit for open repair does not automatically make EVAR worthwhile. ESVS advises against elective repair when life expectancy is limited, pragmatically less than 2–3 years. See Abdominal aortic aneurysm for repair thresholds and selection. [1]

Consent

Discuss rupture prevention, faster recovery and continuing surveillance/reintervention needs, against open repair, complex repair when appropriate, or conservative care. Individualise risks: groin pain/bruising and wound problems; bleeding/transfusion or arterial repair; myocardial infarction, stroke or death; kidney injury/dialysis; limb ischaemia, occasionally amputation; bowel/pelvic ischaemia and sexual dysfunction; rare paralysis; graft infection, endoleak, migration, occlusion and late rupture. Explain possible adjunct procedures, open conversion and later reintervention. [1,4,6–8]

2. Anatomy & planning

Use thin-slice CTA with centreline reconstruction from the visceral aorta through both common femoral arteries (CFAs). Measure diameters perpendicular to the centreline, using the exact IFU’s inner-/outer-wall convention and sizing chart. [3,4,6]

  • Proximal seal: lowest renal and accessory renal origins; usable neck length, diameter, taper, angulation, thrombus and calcium. The covered fabric must preserve the planned renal arteries while obtaining circumferential seal. Consider preserving accessory renals ≥4 mm or supplying more than one-third of the kidney, without compromising seal. [1,3]
  • Body and limbs: renal-to-bifurcation length, terminal-aortic width, gate position and room for two limbs. Measure to each healthy distal landing zone and allow the required component overlap. A narrow distal aorta risks limb competition. [3,4]
  • Distal seal: iliac diameter, healthy landing length and both internal iliac origins. If common iliac disease requires external iliac extension, plan pelvic perfusion first; preserve at least one internal iliac artery during iliac aneurysm repair. [1,3,4]
  • Access: CFA puncture/closure zone, calcium, minimum iliac lumen, tortuosity and thrombus against the delivery system’s outer profile. [3–5]

Endovascular strategy

Choose the main-body side for safe delivery, suitable body length and achievable gate cannulation. Select percutaneous access or cut-down from CFA anatomy, closure suitability and experience; plan iliac angioplasty or a conduit if delivery is doubtful. Unexpected resistance is a stop-and-reassess point, not a reason to push harder. [1,3–5]

Match device configuration to the neck, bifurcation and iliacs. Know the fabric markers, fixation level, permitted repositioning and irreversible release steps. A bare suprarenal fixation stent may cross the renals; covered fabric cannot. Size and overlap from the exact component IFUs, not a generic oversizing rule. [3,6]

An inadequate seal zone needs another strategy—open repair, fenestrated/branched repair, an iliac branch solution or conservative care. Elective EVAR outside IFU is not recommended. Infection or relevant material allergy also requires reassessment. Anticipate cuffs, limb extensions, covered stents and open conversion. If bifurcated completion fails, an aorto-uni-iliac (AUI) bailout requires contralateral common iliac exclusion and femorofemoral bypass. [1,3,4,6]

Common graft families: what actually changes

SystemConstruction and fixationDeployment distinctionPlanning implication
Medtronic Endurant II / IIsPolyester graft on nitinol stents; suprarenal fixation with a separate infrarenal seal.Controlled release with tip capture. II has a longer aortoiliac body; IIs has a shorter aortic body with separate limbs on both sides.Body configuration changes renal-to-bifurcation and limb-length planning. Medtronic’s UK safety information for Endurant II lists neck length ≥10 mm, infrarenal angle ≤60°, aortic neck diameter 19–32 mm, iliac diameter 8–25 mm and distal fixation ≥15 mm. Verify the stocked II/IIs components against their current regional IFU. [9,10]
Cook Zenith FlexPolyester graft on stainless-steel Z stents; a barbed bare suprarenal stent fixes the body.Z-Trak releases sequentially by sheath, trigger wire and top cap. Adjust position before barbed suprarenal fixation; do not reposition after it engages.The cited IFU specifies neck length ≥15 mm, aortic neck diameter 18–32 mm and distal iliac fixation >10 mm, with diameters measured outer wall to outer wall. Check its other access, angulation and component requirements. [6]
Gore Excluder AAA with C3 deliveryePTFE graft on a nitinol framework with active infrarenal fixation.The proximal end can be reconstrained and repositioned at the specified stage before final release; it is not freely movable afterwards.Gore’s published U.S. indications list neck length ≥15 mm, angle ≤60°, aortic neck treatment diameter 19–32 mm and distal iliac seal ≥10 mm (diameter 8–25 mm). Check the regional eIFU. Excluder Conformable is a different product with different criteria. [11–13]

Learn the differences; do not use this table as a sizing chart. The exact model, component and current regional IFU govern selection and deployment. [9–13]

3. Setup

  • Brief: agree body side, renal reference, modules/overlap, distal landings, pelvic perfusion, access/closure and bailout triggers. Check availability, compatibility, packaging and expiry; flush/de-air as instructed. [3,4,6]
  • Patient and room: supine on a radiolucent table; prepare abdomen and both groins for conversion. Record pedal signals. Choose general, regional or local anaesthesia with sedation according to physiology, cooperation and access; an iliac conduit usually requires general anaesthesia. Agree haemodynamic monitoring and renal protection; check creatinine, haemoglobin, coagulation, allergies and blood availability. Minimise contrast and radiation. [1,3–5]
  • Equipment: ultrasound/fluoroscopy, angiographic and shaped catheters, soft and stiff wires, compatible sheaths/closure devices, graft components, moulding balloon and endovascular/open rescue equipment. [3–5]
  • Medication: give IV antibiotic prophylaxis. For elective EVAR, give IV heparin 50–100 IU/kg, timed to safe access and before prolonged large-sheath instrumentation; ACT may guide redosing. Agree an alternative for heparin-induced thrombocytopenia. Continue established aspirin/clopidogrel monotherapy when appropriate; plan DAPT/anticoagulant interruption and restart individually. After recent PCI, defer repair if possible; unavoidable EVAR under DAPT may be considered. [1]

4. Perform

Phase A — Secure access and establish support

Use ultrasound for percutaneous CFA puncture: choose a suitable anterior wall below the inguinal ligament, above the bifurcation and over the femoral head. Confirm access level before large-bore upsizing; correct an unsafe puncture. Place preclose sutures before upsizing when using that technique, or expose/control the artery for open repair. [1,3–5]

Advance a soft wire and catheter into the descending thoracic aorta, then exchange through the catheter for a supportive stiff wire. Position its atraumatic tip below the arch as the IFU requires; monitor it throughout exchanges and delivery, avoiding branch entry or arch manipulation. Retain secure wire access during sheath changes. [3–5]

Phase B — Establish the renal reference and position the body

Advance the main body under fluoroscopy without force. With the delivery system in position, obtain angiography that opens the lowest renal origin and minimises parallax: wires and hardware can shift the anatomy. Identify both main renals, relevant accessory branches and the planned fabric edge. Confirm gate orientation. [3,4]

Deploy at the intended infrarenal level in the exact IFU sequence, maintaining support and watching the fabric edge. Reconfirm position before irreversible release. Body release, gate cannulation and limb deployment may be interleaved; do not assume the body must be fully released first. [3,6]

Phase C — Prove the gate and complete both limbs

Cannulate the contralateral gate with a soft wire and shaped catheter. If difficult, change projection, catheter or sheath support; escalate to a planned snare technique rather than repeatedly probing the fabric. Prove the catheter and wire are inside the graft before stiff-wire exchange and limb delivery. Use angiography/additional views as required; a pigtail spin alone does not replace IFU confirmation. [3–6]

Image each iliac bifurcation, confirm limb length and required overlap, then deploy to healthy distal seal while preserving planned internal iliac flow. Complete remaining body release and ipsilateral components in device order. Check for limb twist, compression or excessive overlap at the flow divider. [3,4,6]

Phase D — Mould, check and close

Mould the seals and junctions with a compliant balloon as the IFU directs. Avoid aggressive inflation in fragile/calcified vessels; keep inflation within the permitted graft segment and fully deflate before moving. [3,4,6]

Relax or exchange stiff wires when safe to reveal natural iliac geometry. Perform completion imaging using the checks below, correct defects and re-image. Withdraw systems under fluoroscopy and inspect access vessels. Close percutaneously or openly, retaining bailout wire access as long as the closure method allows; confirm haemostasis and distal signals. [3–6]

5. Technical pearls & pitfalls

  • Seal and fixation are different: secure fixation does not rescue an inadequate landing zone. [3]
  • A wire can look central while outside the graft: uncertain gate access must be resolved before limb delivery. [3,6]
  • Stiff wires can hide a kink or create a false stenosis: judge the final geometry after relaxing support. [3,4]
  • Do not routinely embolise the IMA/lumbars or perform non-selective sac embolisation to prevent type II endoleak. [1]

For detailed puncture and closure teaching, see Percutaneous Access, Sheaths & Closure Devices.

6. Completion

Verify and document: [3,4,6]

  • Proximal: planned fabric position, renal perfusion and satisfactory seal without type Ia leak.
  • Body: adequate overlap, no type III endoleak and no flow-divider compression.
  • Distal: patent untwisted limbs, satisfactory bilateral seal without type Ib leak and planned internal iliac perfusion.
  • Access: no rupture, flow-limiting dissection or embolisation; secure groins and preserved pedal signals.

Record any residual endoleak, implanted components, adjuncts, contrast/radiation exposure and the follow-up plan. A normal completion angiogram does not replace surveillance.

7. Complications & rescue

ProblemAction
Type I endoleak: proximal Ia or distal Ib seal failureReassess seal and projection; remould appropriately, then extend/reconstruct the landing zone. Preserve renal/pelvic perfusion. Persistent type I leakage needs prompt treatment, not routine observation. [1,3,4]
Type III endoleak: component separation or fabric failureBridge the separation or reline with adequate overlap; re-image. Treat promptly. [1,3]
Renal flow lostUrgent selective imaging: distinguish fabric coverage from embolus/dissection. Restore flow endovascularly where feasible; obtain surgical rescue if unsuccessful. Avoid blind traction on a fixed graft. [3,4]
Iliac rupture or major access bleeding: hypotension, extravasation or expanding haematoma; bleeding may be concealedResuscitate, maintain wire access and obtain proximal balloon control; covered stent or open repair. Closure failure may need sheath replacement or surgical exposure. [3,4]
Lost pedal signal or poor limb flowImage graft, iliac and CFA; exclude kink, compression, dissection, thrombus or embolus. Correct the mechanical cause and restore flow, including thrombectomy when needed; verify runoff. [3,4]
Bowel/pelvic ischaemia: abdominal pain, bloody stool or persistent acidosisUrgent senior assessment and colorectal/critical-care involvement. Assess perfusion, restore flow where possible and evaluate bowel viability. Patent large vessels on CTA do not exclude bowel ischaemia. [1,4]

Type II endoleak is retrograde branch flow, usually from lumbar arteries or the IMA. Exclude type I/III before labelling an uncertain leak type II. Persistence alone does not justify treatment: ESVS considers intervention only with sac growth ≥10 mm from baseline or the smallest previous diameter, using the same imaging/measurement method and excluding other causes. NICE uses sac expansion without a numerical threshold. [1,2]

8. Postoperative management

Monitor haemodynamics, haemoglobin/groins, pedal signals, urine output/creatinine and abdominal or neurological symptoms; high-risk patients need early HDU/ICU monitoring. Escalate hypotension, new severe pain, oliguria or limb perfusion change. Provide analgesia, appropriate hydration, mobilisation and risk-based VTE prophylaxis; continue statin, appropriate antiplatelet therapy, smoking cessation and blood-pressure management. [1]

Surveillance

Obtain CTA within 30 days to assess endoleak, overlap and actual seal length. If unsuitable, agree alternative imaging: duplex alone does not fully assess seal/overlap. [1]

For standard EVAR with established device durability, ESVS proposes: [1]

  • Low risk: no endoleak, within IFU, adequate overlap and ≥10 mm proximal/distal seal, without high-risk anatomy. Consider reduced imaging frequency during the first five years, with reassessment at five years.
  • Higher risk: type II leak, seal <10 mm or insufficient overlap, outside IFU, neck diameter >30 mm, neck angulation >60° or iliac diameter >20 mm. Consider annual CTA/duplex and reassess risk each time.
  • Failure: type I/III leak, deteriorating seal or significant sac growth needs assessment for reintervention. Investigate growth even without a visible leak.

Reconcile intervals with the device IFU and local protocol; new devices and complex repairs need individual schedules. Continue long-term imaging after five years, reconsidering its benefit if elective reintervention would no longer be appropriate. Compare sac size consistently with baseline and its smallest recorded diameter. [1,6]

For suspected endoleak, use CTA, or contrast-enhanced ultrasound if CTA is contraindicated; negative colour duplex alone does not exclude a leak. Give implant details, warning symptoms and a booked scan before discharge. [2,6–8]

9. Remember

Plan the seals → secure access → identify the fabric edge → prove the gate → complete two patent limbs → correct defects → close safely → maintain surveillance.

References

  1. Wanhainen A, Van Herzeele I, Bastos Goncalves F, et al. ESVS 2024 Clinical Practice Guidelines on the Management of Abdominal Aorto-Iliac Artery Aneurysms. Eur J Vasc Endovasc Surg. 2024;67:192–331. doi:10.1016/j.ejvs.2023.11.002.
  2. National Institute for Health and Care Excellence. Abdominal aortic aneurysm: diagnosis and management. NG156. Recommendations.
  3. Sidawy AN, Perler BA, editors. Rutherford’s Vascular Surgery and Endovascular Therapy. 10th ed. Elsevier; 2023.
  4. Chaikof EL, Cambria RP, editors. Atlas of Vascular Surgery and Endovascular Therapy: Anatomy and Technique. Saunders; 2014.
  5. Schneider PA. Endovascular Skills: Guidewire and Catheter Skills for Endovascular Surgery. 4th ed. CRC Press; 2020.
  6. Cook Medical. Zenith Flex AAA Endovascular Graft with the Z-Trak Introduction System: Instructions for Use. T_ZAAAF_REV4. Device-specific reference; the current local IFU for the implanted system governs its use.
  7. Oxford University Hospitals NHS Foundation Trust. Endovascular Aneurysm Repair (EVAR). April 2026. Patient information.
  8. Guy’s and St Thomas’ NHS Foundation Trust. Endovascular aneurysm repair—EVAR. Patient information.
  9. Medtronic. Endurant II/IIs stent graft system—UK product information.
  10. Medtronic. Endurant II—UK important safety information. Its listed limits concern Endurant II; the exact II/IIs manual governs.
  11. W. L. Gore & Associates. Excluder AAA Endoprosthesis—published U.S. indications.
  12. W. L. Gore & Associates. Overview of the Excluder device family.
  13. W. L. Gore & Associates. Excluder AAA with C3 delivery—device update.